29 C
Vientiane
Tuesday, April 29, 2025
spot_img
Home Blog Page 16

Introducing Reversec: Shaping the future of offensive cybersecurity

New company unites decades of experience to deliver consulting services grounded in pioneering research

STOCKHOLM, April 28, 2025 /PRNewswire/ — Reversec launches today as a new name in cybersecurity consulting, dedicated to helping businesses overcome their most complex security challenges. Formerly known as the Consulting unit of WithSecure, Reversec focuses on turning pioneering research into practical solutions that help organizations stay ahead of threats.

With an emphasis on offensive, proactive, strategies, Reversec ensures businesses are prepared to tackle evolving security risks. By combining deep industry experience with a commitment to continuous research, Reversec delivers straightforward and effective services that not only protect but also strengthen its clients’ operations.

Launching Reversec as a new company allows us to focus on being a nimble, research-led cybersecurity consultancy with an aim to redefine offensive security” said Scott Reininga, Executive Vice President of Reversec. “We adopt a hacker mindset, simulating the tactics and strategies used by cybercriminals so we can turn complex security challenges into clear solutions and make cybersecurity a strategic advantage for our clients.”

Reversec unites expertise from leading names in the cybersecurity world, including MWR Infosecurity, F-Secure, WithSecure, nSense, and Inverse Path. With over three decades of combined experience, the team brings unmatched knowledge to help organizations build stronger defenses and reduce risks. Reversec is also committed to openly sharing its expertise with clients and the wider community, encouraging informed decisions about security.

For more details about Reversec, visit www.reversec.com.

About Reversec

At Reversec, we help organizations tackle their most complex cybersecurity challenges. Our offensive-driven consulting services ensure our clients stay ahead of emerging threats.
 
Continuous research is at the core of what we do. We believe true protection comes from investing in pioneering security research and translating those insights into practical, real-world solutions for our customers.
 
We openly share our research and expertise with you, and the wider community, to help make informed decisions about security. Our research findings provide the rationale behind our recommendations, ensuring you understand and trust our approach.
 
Our vision is to be the leading global provider of offensive-driven consulting services. With some of the industry’s brightest minds, we’ve helped organizations worldwide strengthen their defenses and mitigate cyber risks.

Media Contact

Kelly Friend
kelly.friend@reversec.com
+44 (0)7880 488357

James E. Malackowski Recognized with the Highest Honor in Intellectual Property Licensing

The Licensing Executives Society International presents a Gold Medal to Ocean Tomo Co-founder James E. Malackowski.

SINGAPORE and JERICHO, N.Y., April 28, 2025 /PRNewswire/ — J.S. Held announces that the Licensing Executives Society International (LES) has recognized intellectual property expert James E. Malackowski with its highest honor in the business of intellectual property – the LES Gold Medal. Mr. Malackowski was presented with the LES Gold Medal for his exceptional contribution to LESI and the licensing profession during the 2025 LES International Annual Conference in Singapore. He is only the 31st recipient of the LES Gold Medal, first awarded in 1971. 

-

Notably, Mr. Malackowski joins only six others who have received the LES Gold Medal and inclusion in the IP Hall of Fame, a combination generally regarded as the ultimate recognition in the IP services industry. Mr. Malackowski was inducted as the 87th member of the IP Hall of Fame in 2022. 

Others who have been similarly recognized with both such awards are Dudley B. Smith who was instrumental in forming the Licensing Executives Society; Heinz Goddar who is widely regarded as a global IP luminary dedicating his career to advancing the understanding of IP across academia, research, governmental, and commercial enterprises; Thierry Sueur who helped shape IP policy in his role at the International Chamber of Commerce as well as his work as chairman of the IP Committee of the French business federation MEDEF and vice chairman of the board of the French Patent Office; Francis Gurry as the former Director General of the World Intellectual Property Organization (WIPO); Randall R. Rader as former Chief Judge of the United States Court of Appeals for the Federal Circuit; and, Hon. Pauline Newman who was appointed to the United States Court of Appeals for the Federal Circuit in 1984. 

Mr. Malackowski’s latest award follows annual recognition since 2007 by leading industry publications. He has been included as one of the ‘World’s Leading IP Strategists’; listed among “50 Under 45” by IP Law & Business™; included in the National Law Journal’s inaugural list of 50 Intellectual Property Trailblazers & Pioneers; named as one of “The Most Influential People in IP” by Managing Intellectual Property™; selected as 1 of 50 individuals, companies, and institutions that framed the first 50 issues of IAM Magazine; and noted as 1 of 60 leading global Economics Expert Witnesses by the same publication. In 2011, Mr. Malackowski was selected by the World Economic Forum as one of less than twenty members of the Network of Global Agenda Councils to focus on questions of IP policy. In 2013, he was inducted into the Chicago Area Entrepreneurship Hall of Fame by the Institute for Entrepreneurial Studies at the University of Illinois at Chicago College of Business Administration.

Mr. Malackowski is widely known for his work to develop a more efficient and transparent market for IP rights, including oversight for the Ocean Tomo 300® Patent Index, the first large-scale public auction for patents, the framework for the Intellectual Property Exchange International, and the current online market for patent sales—OceanTomoBidAsk.com. Mr. Malackowski has led the publication of the Ocean Tomo Intangible Asset Market Value® study for more than twenty years documenting the transition of global markets from tangible assets to intangible assets driven. Malackowski’s firm continues to update this study, which has been downloaded and cited by third parties on more than 150,000 occasions.

Mr. Malackowski has focused his not-for-profit efforts with organizations leveraging science and innovation to benefit children and students, including those in less developed countries. He served for more than twenty years as a Trustee or Director of the National Inventors Hall of Fame, Inc., an organization providing summer enrichment programs for more than 100,000 students annually. For more than ten years, Mr. Malackowski served as a Director of Chicago’s Stanley Manne Children’s Research Institute, advancing the organization’s agenda to measure and report the impact of its pediatric research.

Mr. Malackowski is a frequent speaker on emerging technology markets and related financial measures. He has addressed mass media audiences, including Bloomberg Morning Call, Bloomberg Evening Market Pulse, Bloomberg Final Word, CNBC Closing Bell, CNBC On the Money, CNBC Street Signs, CNBC World Wide Exchange, CBS News Radio, and Fox Business National Television, as well as other recognized news-based internet video channels.

As an inventor, Mr. Malackowski has twenty issued U.S. patents. He is a frequent instructor for graduate studies on IP management and markets and a Summa Cum Laude graduate of the University of Notre Dame, majoring in accountancy and philosophy. He is a Certified Licensing Professional and a Registered Certified Public Accountant in the State of Illinois.

About Ocean Tomo

Ocean Tomo provides Expert Opinion, Management Consulting, Advisory, and Specialty Technical Services focused on matters involving intellectual property (IP) and other intangible assets. Practice offerings address economic damage calculations and testimony; business licensing strategy and contract interpretation; patent-focused business intelligence; portfolio development strategy; litigation support; trade secret reasonable measures; asset and business valuation; strategy and risk management consulting; merger and acquisition advisory; debt and equity private placement; and IP brokerage.

About J.S. Held

J.S. Held is a global consulting firm that combines technical, scientific, financial, and strategic expertise to advise clients seeking to realize value and mitigate risk. Our professionals serve as trusted advisors to organizations facing high stakes matters demanding urgent attention, staunch integrity, proven experience, clear-cut analysis, and an understanding of both tangible and intangible assets. The firm provides a comprehensive suite of services, products, and data that enable clients to navigate complex, contentious, and often catastrophic situations.

More than 1,500 professionals serve organizations across six continents, including 84% of the Global 200 Law Firms, 75% of the Forbes Top 20 Insurance Companies (90% of the NAIC top 50 Property & Casualty Insurers), and 71% of the Fortune 100 Companies.

Verdantix, in their Green Quadrant: Enterprise Risk Management Consulting Services (2025) report, benchmarks 15 of the most prominent enterprise risk management (ERM) advisors, identifying global consulting firm J.S. Held among the leading companies based on capabilities and momentum.

J.S. Held, its affiliates and subsidiaries are not certified public accounting firm(s) and do not provide audit, attest, or any other public accounting services. J.S. Held, its affiliates and subsidiaries are not law firms and do not provide legal advice. Securities offered through PM Securities, LLC, d/b/a Phoenix IB, a part of J.S. Held, member FINRA/ SIPC, or Ocean Tomo Investment Group, LLC, a part of J.S. Held, member FINRA/ SIPC. All rights reserved.

Kristi L. Stathis | Global Public Relations | +1 786 833 4864 | Kristi.Stathis@jsheld.com

Sonitus Medical and BHM Establish Strategic Cooperation

SHANGHAI, April 28, 2025 /PRNewswire/ — Sonitus Medical has entered into a strategic cooperation with BHM, a renowned European manufacturer of bone conduction hearing devices. The two companies will engage in deep collaboration across product development, manufacturing, regulatory approval, marketing, and sales. Under the agreement, Sonitus Medical grants BHM the commercialization rights outside of China for two innovative bone conduction hearing products developed by Sonitus. BHM, together with its parent company MED-EL, a global leader in implantable hearing solutions, will promote and distribute the products through MED-EL’s extensive marketing network, which spans more than 130 countries.

“The medical-grade bone conduction market for patients with conductive hearing loss, single-sided deafness, and mixed hearing loss is still in its infancy in China, but holds tremendous potential. In China, Sonitus Medical is already the leader in this niche segment. We are dedicated to developing innovative, high-quality, non-invasive bone conduction hearing solutions. Our products undergo rigorous clinical audiology validation and meet world-class standards. An increasing number of hearing-impaired individuals in China rely on Sonitus Medical’s products in their daily lives and work,” said Shawn Pu, Chairman of Sonitus Medical.

“We are very pleased to have reached a strategic cooperation with BHM. BHM is a renowned European company specializing in the research and production of medical-grade bone conduction devices. Its parent company, MED-EL, is a global pioneer and leader in implantable hearing solutions. This strategic cooperation signifies recognition of the Sonitus Medical team’s innovation capabilities by an important partner, and we are truly honored. We firmly believe that Sonitus Medical can bring greater value to our partners through this collaboration, and together, we can provide better products for hearing-impaired people worldwide. We wish this cooperation great success!” said Pu.

 “Even in relatively mature hearing markets like Europe and the United States, there remain many unmet needs among patients with conductive hearing loss, single-sided deafness, and mixed hearing loss. There is still significant growth potential for medical-grade bone conduction hearing devices, especially innovative and high-quality non-invasive solutions. Not long ago, MED-EL, the global leader in implantable hearing solutions, acquired BHM, which signals a strong push in this field,” said Markus Hütter, Managing Director of BHM. “Before this framework agreement, BHM had already established a successful business relationship with Sonitus Medical. We are delighted to move forward into a deeper strategic cooperation. Sonitus Medical is a dynamic and creative team with deep understanding and experience in medical-grade bone conduction. Through our collaboration, we hope to better leverage the efficiency, quality, and cost advantages of the Chinese supply chain, combined with our brand and marketing strengths in global markets—particularly the mature European and American markets—to offer patients newer and better solutions. I believe this is a truly win-win cooperation.”

About Sonitus Medical

Sonitus Medical originates from Silicon Valley in the United States and is now based in the Zhangjiang International Medical Park in Shanghai. The company specializes in the research, development, and manufacturing of medical-grade bone conduction hearing devices that meet international clinical standards, providing innovative hearing solutions for patients around the world. Sonitus Medical holds over 100 global invention patents and ranks among the top in China’s hearing industry. Sonitus Medical is a non-invasive, medical-grade bone conduction expert, offering the most comprehensive range of non-invasive bone conduction hearing solutions currently available on the market. The company pioneered the SoundBite hearing system, the world’s FIRST non-surgical and removable hearing solution that imperceptibly transmits sound via the teeth as bone conduction, which was ranked No.1 on the “Top 10 U.S. Medical Innovations of the Year” by the Cleveland Clinic. This revolutionary system achieves Direct-Drive bone conduction through a non-invasive approach, with clinical hearing outcomes comparable to or even better than surgically implanted bone-anchored hearing aids. Sonitus Medical has developed a variety of high-quality, non-invasive bone conduction hearing solutions for people of all ages with conductive hearing loss, single-sided hearing loss, and mixed hearing loss. These include glasses-style, headband-style, adhesive bone conduction hearing aids, etc. For more information, please visit: www.sonitus.com.

About BHM

BHM – the Berl Hörgeräte Manufaktur – develops high-quality hearing aid systems, carefully manufactured by hand in Austria and distributed around the world. Its core competence – the continual development and precise manufacture of hearing systems and bone conductors – combines craftmanship with high-end technology. As a trailblazer in hearing aids, accessories and precision components for the medical technology field, BHM also produces highly sophisticated micro-components and components for hearing and prosthesis parts. Many years of experience and its commitment to perfectionism make BHM a globally sought-after specialist in bone conduction and special hearing systems. MED-EL acquired BHM in 2024. For more information, please visit: www.bhm-tech.at.

About MED-EL

MED-EL Medical Electronics, a leader in implantable hearing solutions, is driven by a mission to overcome hearing loss as a barrier to communication and quality of life. The Austrian-based, privately owned business was co-founded by industry pioneers Ingeborg and Erwin Hochmair, whose ground-breaking research led to the development of the world’s first micro-electronic multi-channel cochlear implant (CI), which was successfully implanted in 1977 and was the basis for what is known as the modern CI today. This laid the foundation for the successful growth of the company in 1990, when they hired their first employees. To date, MED-EL has more than 2,800 employees from around 80 nations and 30 locations worldwide. The company offers the widest range of implantable and non-implantable solutions to treat all types of hearing loss, enabling people in 137 countries enjoy the gift of hearing with the help of a MED-EL device. MED-EL’s hearing solutions include cochlear and middle ear implant systems, a combined electric acoustic stimulation hearing implant system, auditory brainstem implants as well as surgical and non-surgical bone conduction devices. For more information, please visit: www.medel.com.  

Manulife Launches Two New Critical Illness Plans: IncomeGuard and IncomeShield Offer Market-Leading Annual Critical Illness Payouts for Potential Income Loss During Long-term Treatments

IncomeGuard and IncomeShield introduce a m arket-first[1] heart attack/stroke continuous treatment benefit offering up to 100% coverage[2]for each payout following receipt of a major critical illness benefit, along with total critical illness coverage of up to 1,000% and 500%, respectively, of notional amount

IncomeShield also features s implified underwriting procedures with just three health questions

HONG KONG, April 28, 2025 /PRNewswire/ — Manulife Hong Kong today announced the launch of two new critical illness plans designed to offer customers market-leading annual critical illness payouts, helping to mitigate potential income loss during long-term treatment. The IncomeGuard Critical Illness Protector covers 121 critical illnesses and diseases, providing a market-first[1] heart attack/stroke continuous treatment benefit with up to 100% of the notional amount upon diagnosis of a heart attack or stroke for subsequent specified complex or major surgeries, following the receipt of major critical illness benefit. The IncomeShield Critical Illness Protector delivers focused protection for cancer, heart diseases, and stroke, featuring simplified underwriting with as few as three health questions. Together, these plans provide essential financial support tailored to the diverse needs of customers facing serious health challenges.

Darren Thompson, Chief Product Officer_Manulife Hong Kong and Macau
Darren Thompson, Chief Product Officer_Manulife Hong Kong and Macau

Manulife’s research[3] reveals that consumers seeking critical illness coverage prioritize three key factors: coverage for a wide variety of critical illnesses (53%), the availability of various value-added services to support them during illness (39%), and coverage for recurring critical illnesses (37%). In addition, upon diagnosis, 39% of surveyed consumers identified their immediate concern, ranked among the top three, as losing their ability to work and their income-earning potential. This was closely followed by 34% who cited becoming a burden to their family and needing care as their next most pressing issue. Yet, even as they contemplate securing insurance coverage for critical illnesses, one of their top concerns is the higher premiums that come with increasing age (25%). These findings underscore the importance of financial stability in helping consumers focus on their recovery and providing them with peace of mind.

The IncomeGuard Critical Illness Protector offers extensive coverage for 121 critical illnesses and diseases, including 60 major critical illnesses, 44 early-stage critical illnesses, and 17 juvenile diseases. Key features include:

  • Extra  coverage : Provides up to 100% extra critical illness coverage if the life insured is diagnosed with a major critical illness, an early-stage critical illness and/or juvenile disease, or passes away within the first 10 policy years[4]. This offers annual income support, with coverage of up to 1,000% of the notional amount[5] from diagnosis to  treatment for cancer, heart attack, and stroke. 
  • [Market-first[1] ] Heart attack/stroke continuous treatment benefit: Upon diagnosis of a heart attack or stroke following the receipt of a major critical illness benefit, this feature offers extra protection with each payout of up to 100% of the notional amount for subsequent specified complex or major surgeries.
  • Premium waiver: Premiums for the basic plan are waived for 12 months starting from the premium due date immediately after the diagnosis date of an early-stage critical illness or juvenile disease once benefits are paid. All future premiums for the basic plan are also waived following the diagnosis of a major critical illness after benefits are paid.
  • Traditional Chinese medicine: Offers reimbursement for traditional Chinese medicine related to cancer treatment, supporting the recovery journey.
  • Protection Restore Benefit: This benefit provides the total amount previously paid for an early-stage critical illness and juvenile disease that occurred at least a year ago if the life insured has a major critical illness or passes away before the age of 85, providing the life insured with much-needed financial support.
  • Guaranteed premium: The premium amount remains unchanged throughout the payment period, with terms available for 10, 20, or 25 years.[6]

The IncomeShield Critical Illness Protector is designed for customers seeking focused protection against cancer, heart diseases, and stroke. Key features include:

  • Simplified underwriting: Answer just three health questions, mainly focused on health conditions from the past two years, provided that the insured has not been diagnosed with specified diseases.
  • Steady financial support: This offers annual income support, with coverage of up to 500% of the notional amount[7] from diagnosis to treatment for cancer, heart attack, and stroke.
  • [Market-first[1] ] Heart attack/stroke continuous treatment benefit: Upon diagnosis of a heart attack or stroke following the receipt of a major critical illness benefit, this feature offers extra protection with each payout of up to 100% of the notional amount for subsequent specified complex or major surgeries.
  • Late-stage Cancer Advanced Benefit: Provides a one-time advanced payout equal to 100% of the notional amount upon diagnosis of late-stage cancer.[8]
  • Premium waiver: All future premiums for the basic plan are waived after the diagnosis date of a major critical illness, once benefits are paid.
  • Protection Restore Benefit: This benefit provides the total amount previously paid for an early-stage critical illness that occurred at least a year ago if the life insured has a major critical illness or passes away before the age of 85, providing the life insured with much-needed financial support.
  • Guaranteed premium: The premium amount remains unchanged throughout the payment period, with terms available for 10, 20, or 25 years.[6]

Darren Thompson, Chief Product Officer, Manulife Hong Kong and Macau, said: “With rising medical costs and the financial burden of critical illnesses, it is essential for Manulife to offer our customers accessible and holistic insurance solutions that protect themselves and their loved ones during challenging times. While many consumers view critical illness plans as a means to cover treatment expenses, they also serve as a vital income replacement tool. When diagnosed with a critical illness, people often need to take time off for treatment and recovery, leading to significant income loss. This makes critical illness plans invaluable in providing financial stability, allowing individuals to focus on their treatment and recovery journey.”

To provide better support for customers diagnosed with cancer, Manulife’s CancerCompanion Service[9], is now available as a value-added service through a Healthcare Hotline Team and Personalized Medical Case Managers[10], who are qualified nurses with extensive healthcare experience, to guide customers diagnosed with cancer through treatment and recovery. The services feature the industry-leading[11] Cancer Drug Support Service[12], which includes limousine service in collaboration with Prosper Health and Shenzhen New Frontier United Family Hospital, as well as a second medical opinion service to be provided by specialists at Gleneagles Hospital Hong Kong, HKSH Medical Group, CUHK Medical Centre, and all United Family Hospitals. Additionally, discounted cancer check-up packages and dietitian services are available through selected medical service providers[13],[14].

 Terms and conditions apply. For more details and risks about IncomeGuard and IncomeShield, please click on the provided links to access the respective product leaflets.

The content of this press release does not contain the full terms of the policy(ies), and the full terms can be found in the corresponding policy document(s). Before making a purchase, customers are encouraged to read the policy provisions for the exact terms and conditions that apply to these products.


[1] Based on comparisons with other publicly available critical illness plans issued by Hong Kong’s major life insurance companies for individual customers as of April 27, 2025.

[2] For heart attack/stroke continuous treatment benefit, the total amount payable is up to 400% of the notional amount.

[3] Manulife conducted an online survey in December 2024 to gather insights into the needs and preferences of Hong Kong consumers regarding critical illness products. The survey sampled 501 adults aged 25 to 54 with a monthly household income of HK$30,000 or above in Hong Kong.

[4] If the life insured is diagnosed with a major critical illness, the IncomeGuard Critical Illness Protector will pay an additional payout equal to 100% of the major critical illness benefit (excluding any terminal bonus) and any protection restore benefit paid. If the life insured is diagnosed with an early-stage critical illness and/or juvenile disease, the IncomeGuard Critical Illness Protector will pay an additional payout equal to 100% of the amount of the benefit paid for that illness and/or disease. 

[5] Benefit payouts of up to 1,000% of the notional amount include: (1) major critical illness benefit, (2) cancer diagnosis benefit, (3) cancer continuous treatment benefit, (4) heart attack /stroke continuous care benefit, and (5) heart attack /stroke continuous treatment benefit.

[6] It is guaranteed that the basic plan premiums for the initial basic plan notional amount remain unchanged throughout the premium payment period. However, the premium and guaranteed cash value due to an increase in the basic plan notional amount, including those increases triggered by using the inflation protector option, are not guaranteed.

[7] Benefit payouts of up to 500% of the notional amount include: (1) major critical illness benefit, (2) late-stage cancer advanced benefit, (3) cancer diagnosis benefit, (4) cancer continuous treatment benefit, (5) heart attack /stroke continuous care benefit, and (6) heart attack /stroke continuous treatment benefit.

[8] If the late-stage cancer advanced benefit has been paid, the total payable amount of the cancer continuous treatment benefit will be reduced by 100% of the notional amount.

[9] The services covered by the CancerCompanion Service are administrative arrangements and are not part of the product features. For the avoidance of doubt, the use of the service does not imply any expenses or diagnoses associated with the service are covered in the insurance policy(ies). Manulife reserves the right to change designated medical services provider(s) for each service from time to time, or revise or terminate these services at any time without prior notice. Manulife and its insurance advisors do not have relevant licenses and/or qualifications to provide medical services. Medical service providers are independent contractors and are not employees, agent, or servants of Manulife. Manulife shall not be responsible and/or liable for any services, diagnosis, advice or treatment or other acts or omissions of medical service providers. Manulife shall not be liable for any acts or omission of any other service providers. Unless otherwise specified, all related expenses (such as costs arising from medication, consultations, examinations, tests, etc.) will be borne and paid by the customer. Please note that some of these services are only available to insured persons located in designated regions only (e.g. Hong Kong); please refer to the relevant terms and conditions for details. The CancerCompanion Service is subject to terms and conditions, so please refer to the relevant leaflet for details.

[10] The service is supportive in nature and does not provide diagnosis, treatment or medical advice. The information provided is not medical advice or recommendation. It should not be relied upon by users in their decision making in relation to their medical conditions. If you need any medical care or emergency medical service, please visit a doctor for consultation immediately. The Healthcare Hotline Team service is subject to terms and conditions; please refer to the Holistic “Medical Professional Support Service” leaflet for details.

[11] “Industry-leading” is based on comparisons of the administrative services with other publicly available critical illness plans offered by Hong Kong’s major life insurance companies for individual customers as of March 19, 2025.

[12] Eligibility applies to the Insured of ManuLove Care, ManuPrimo Care/ManuPrimo Care (BestStart), ManuBright Care 2 Plus, ManuBright Care 2, Manulife Bright Care PRO, ManuVital Care, Manulife Supreme VHIS Flexi Plan, Manulife Supreme Lite VHIS Supplementary Benefit, Manulife Supreme Medical Plan, Manulife Supreme Lite Medical Supplementary Benefit, ManuMaster Healthcare Series/Benefits, ManuShine Healthcare Series/Benefits, Manulife First VHIS Flexi Plan, Manulife Shelter VHIS Standard Plan, ManuGuard Medical Plan/Benefit, Cancer Treatment Benefit, ManuEnrich Medical Top-up Plan, IncomeGuard and IncomeShield. The eligible policy(ies) must be without relevant exclusion(s). To be eligible for Cancer Drug Support Service, the Insured must be confirmed with cancer and the respective diagnosis(es) must be supported by a registered medical practitioner. Each eligible Insured can receive at most one Cancer Drug Support Service per life regardless of the number of eligible policies they are insured. Terms and conditions apply.

[13] These services are provided by Manulife’s partnered medical service providers which are not agents of Manulife and do not act on behalf of Manulife. Manulife’s services are supportive in nature and Manulife shall not be responsible or liable for any diagnosis, advice, or treatment or other acts or omissions of medical service providers. Manulife shall not be liable for any acts or omissions of any other service providers.

[14] The arrangement of the services and discount provided by Manulife’s partnered medical service providers may change from time to time without prior notice. The services and discounts are subject to the terms and conditions imposed by Manulife’s partnered medical service providers.

About Manulife Hong Kong

Manulife Hong Kong has been a trusted name for more than 125 years. Since our operations started in Asia in 1897, we have grown to become one of the top-tier providers of financial services, offering a diverse range of protection and wealth products and services to over 2.6 million customers in Hong Kong and Macau. We are committed to helping make decisions easier and lives better for our customers.

Manulife Hong Kong, through Manulife International Holdings Limited, owns Manulife (International) Limited, Manulife Investment Management (Hong Kong) Limited, and Manulife Provident Funds Trust Company Limited. These entities are all subsidiaries of Manulife Financial Corporation.

About Manulife

Manulife Financial Corporation is a leading international financial services provider, helping our customers make their decisions easier and lives better. With our global headquarters in Toronto, Canada, we operate as Manulife across Canada, Asia, and Europe, and primarily as John Hancock in the United States, providing financial advice and insurance for individuals, groups and businesses. Through Manulife Wealth & Asset Management, we offer global investment, financial advice, and retirement plan services to individuals, institutions, and retirement plan members worldwide. At the end of 2024, we had more than 37,000 employees, over 109,000 agents, and thousands of distribution partners, serving over 36 million customers. We trade as ‘MFC’ on the Toronto, New York, and the Philippine stock exchanges, and under ‘945’ in Hong Kong.

Not all offerings are available in all jurisdictions. For additional information, please visit manulife.com.

Sigenergy Becomes Australia’s Top Battery Brand by Market Share, SunWiz Reports

SYDNEY, April 28, 2025 /PRNewswire/ — Sigenergy, a leading energy innovator, was ranked the No. 1 battery manufacturer in Australia by blended capacity[1] for the month of March 2025, according to the latest report from SunWiz, an independent expert solar consultancy. Based on kilowatt-hours (kWh) blended during that month, Sigenergy captured a 17.4% market share—outperforming all other brands. Sungrow and Alpha ESS followed with 17.1% and 15.2% respectively, while Tesla placed fourth.

Sigenergy Becomes Australia’s Top Battery Brand by Market Share, SunWiz Reports
Sigenergy Becomes Australia’s Top Battery Brand by Market Share, SunWiz Reports

This achievement highlights Sigenergy’s rapid rise and growing influence in the Australian energy storage sector. In February, the company was also recognized with the Silver Award by SolarQuotes—Australia’s leading PV installation advisory platform—in its 2025 “Best Batteries in Australia” rankings, placing Sigenergy among the top three battery storage providers nationwide.

Sigenergy’s success in Australia is part of a broader global growth trajectory. According to a recent report by Frost & Sullivan, the company ranked No. 1 globally in the stackable all-in-one Distributed Energy Storage System (DESS) category, shipping 231 MWh from Q1 to Q3 2024 and securing a 24.3% share of the global market. The same report also ranked Sigenergy third in the overall all-in-one DESS segment with a 5.9% share, as the top five manufacturers accounted for 74.5% of total shipments.

Sigenergy’s continued leadership across markets reflects its commitment to advanced technology, dependable performance, and sustainable energy innovation—further strengthening its appeal among Australian consumers and installers alike.

[1] Blended capacity refers to the total energy capacity (in kilowatt-hours, kWh) of residential battery systems proposed, sold, and installed.

Disney Fan’s Wish to Perform on Stage Comes True

Hong Kong Disneyland Resort and Make-A-Wish® Hong Kong team up to grant child’s wish


HONG KONG SAR – Media OutReach Newswire – 28 April 2025 – To celebrate World Wish Day on April 29, Hong Kong Disneyland Resort (HKDL) recently joined with Make-A-Wish® Hong Kong to grant a magical wish for Yee Sun, a brave 7-year-old girl who was diagnosed with biliary atresia at just two months old and a rare type of lymphoma at four years old. She underwent four times of organ and bone marrow transplant, and a series of chemotherapy before she recovered.

Yee Sun became part of “Mickey and the Wondrous Book” show
Yee Sun became part of “Mickey and the Wondrous Book” show

Nearly 1,000 guests witnessed her wish come true as she became part of “Mickey and the Wondrous Book”.

“Who will open the book next? Who has the heart of a storybook hero? Could it be you?” Every time Mickey Mouse asked these questions at the end of “Mickey and the Wondrous Book,” Yee Sun eagerly raised her hand, hoping to be the one Mickey invited on stage.

In battling her critical illness, Yee Sun found strength and inspiration in the show’s magical storytelling. Her one true wish was to become part of the performance, to stand alongside Mickey and step into the story herself – bringing her wish to life in the most enchanting way.

To make her wish come true, HKDL’s Entertainment team meticulously crafted a special pre-show moment for her and an appearance in the show. Dressed in a specially designed costume created by the resort’s Costuming team and treated to a magical makeover and hairstyling in Bibbidi Bobbidi Boutique, Yee Sun was immersed into the show through her experience as a stage performer.

After the show, a bonus surprise moment took place– a greeting by her favorite Disney friend, Queen Elsa, who offered her warm words and praise.

Ahead of this wish coming to life, Yee Sun dedicated herself to practicing choreography and script every day for a month, even adding personal touches to the script to create a truly engaging performance. “I was nervous and excited at the same time, facing such a large audience,” said Yee Sun. “I’m so happy my wish came true!”

Yee Sun’s parents added, “Hong Kong Disneyland is a truly magical place. It’s like stepping into a fairytale. I’m overjoyed that Yee Sun’s wish was granted here. This performance will be an unforgettable memory for her and a wonderful boost to her confidence.”

Adding to the heartwarming occasion, one wish child from Singapore and three from Taiwan, whose wishes were to visit HKDL, also joined this heartwarming moment and witnessed Yee Sun’s wish come true.

“This year is especially meaningful as HKDL celebrates its 20th anniversary, marking two decades of creating happiness and magical moments. Over the years, we have walked alongside Make-A-Wish, granting wishes to children, delivering hope, happiness and joy,” said Michael Moriarty, managing director, Hong Kong Disneyland Resort.

“Hong Kong Disneyland is proud to have granted more than 340 wishes since 2008, reaffirming our commitment to supporting wish children and their families.”

“Children are full of imagination, which makes their dreams boundless and unique, regardless of their health condition. Yee Sun’s special wish reminds our wish children that everyone is the hero of their own story as they showcase extraordinary courage, resilience and strength in the face of critical illnesses,” said Ernest Leung, Board Director of Make-A-Wish Hong Kong.

After this special event, more than 45 representatives from Make-A-Wish Hong Kong and 12 other Make-A-Wish Affiliates across Asia and the Middle East also came together at HKDL for their first-ever offsite roundtable conference in eight years, in which resort representatives shared the resort’s experiences and insights into granting wishes for wish children.

For 45 years, Disney has worked with Make-A-Wish to grant wishes and create happiness and joy for children and families when it’s needed most, in ways that only Disney can. Disney is proud to be the world’s largest wish granter for Make-A-Wish®.

A Disney wish is granted every hour of every day, on average – and it is an honor that wish children choose Disney for their most heartfelt wish. The resort will continue to work with Make-A-Wish Hong Kong and Make-A-Wish International to create magical and memorable moments for children with critical illnesses and their families.

Hashtag: #HKDL #HongKongDisneyland

The issuer is solely responsible for the content of this announcement.

About Make-A-Wish Hong Kong

Make-A-Wish Hong Kong was registered in Hong Kong as a charity (registration number: 91/5366) in 1998 and became a member of Make-A-Wish Foundation International. Our mission is to create life-changing wishes for children with critical illnesses aged between 3 and 17, in Hong Kong and Macau, to enrich the human experience with hope, strength and joy. A wish creates an opportunity for hope and the ability to experience life beyond illness. Serving as a supplement to medical treatment and complement one another as acknowledged by healthcare professionals, we believe that a Wish Journey will bring a transformative impact not just to the child concerned, but also to the child’s family as they tackle some of their most difficult trials in life. To date, Make-A-Wish Hong Kong has transformed over 2,400 children’s lives. We are dedicated to making every eligible child’s wish come true.

About Make-A-Wish International
Make-A-Wish creates life-changing wishes for children with critical illnesses. Founded in 1980, Make-A-Wish is the world’s leading children’s wish-granting organization, having granted more than 615,000 wishes in nearly 50 countries and territories worldwide. Every 25 seconds, a child is diagnosed with a critical illness and becomes eligible for a wish. Wish experiences can restore the childhood stolen by a critical illness diagnosis and improve physical, psychological and emotional well-being. Together with generous donors, supporters, staff and more than 27,000 volunteers around the globe, Make-A-Wish brings the power of a wish-come-true to children and their families when they need it most. For more information about Make-A-Wish International, visit .

About Hong Kong Disneyland Resort

Hong Kong Disneyland Resort offers unforgettable, culturally distinctive Disney experiences for guests of all ages and backgrounds. Filled with your favorite Disney stories and characters, Hong Kong Disneyland Resort offers guests the opportunity to explore eight diverse lands that are home to award-winning, one-of-a-kind attractions and entertainment. Complete your adventure with stays at the resort’s luxurious Disney hotels. The magic doesn’t end at our doorstep; as a dedicated member of the local community that cares deeply about societal wellbeing, Hong Kong Disneyland Resort spreads its magic through community service programs that help families in need, boost creativity among children and families, encourage the protection of the environment and inspire healthier living.

Mobile app gives the latest updates & helps plan your visit
The Hong Kong Disneyland mobile app keeps guests informed of all the excitement at Hong Kong Disneyland Resort, from operating hours to entertainment schedules. Reserve your park visit and get Disney Standby Pass to meet Disney friends inside the park. Use the GPS-enabled map to find your way around the park or make reservations for park and hotel restaurants, and make every moment count with wait times for each attraction. Magic Access members can also view block-out calendars and membership privileges, designed to make your visit even more magical.

Download the Hong Kong Disneyland mobile app for free:
iOS users:
Android users:

Into Tomorrow: VT Markets’ Next Chapter in Trading Innovation

Marking 10 years with exclusive initiatives throughout the year

SYDNEY, April 28, 2025 /PRNewswire/ — VT Markets, a leading multi-asset brokerage, is proud to celebrate its 10th year in the industry. Over the past decade, VT Markets has redefined the landscape of trading to deliver unmatched value to its customers. Looking to the future, VT Markets embraces the theme “Into Tomorrow,” symbolizing our commitment to the next stage of growth and transformation.

VT Markets - 10th Anniversary
VT Markets – 10th Anniversary

A Decade of Evolution and Growth

Since its inception, VT Markets is driven by a clear vision: to innovate and transform the way people trade. From the pioneering of cutting-edge trading technology to the expansion into global markets, VT Markets has always stayed ahead of the curve. The past decade has been a story of transformation—each milestone has played a pivotal role in shaping the company into its success today.

Into Tomorrow, Together

Looking ahead, VT Markets is driven by a renewed sense of purpose. The theme “Into Tomorrow” symbolizes a journey toward the future and a commitment to navigating it with boldness, continually innovating, and reimagining what is possible. Over the next 2-3 years, VT Markets is poised for remarkable growth, with plans to expand its global reach, launch new cutting-edge products, and establish its foothold in emerging markets. The company is determined to explore uncharted territories, set new standards, and reshape the trading landscape, all while remaining true to its commitment to delivering exceptional value to its clients and partners.

“As VT Markets celebrates a decade of growth, we take pride in the foundation we’ve built—one rooted in innovation, trust, and a shared vision to transform the trading experience. This anniversary is a powerful reminder of our commitment to not only evolve as a brand, but to continuously set new benchmarks in the industry. Moving forward, we’re focused on expanding our impact, forging new paths, and delivering exceptional value for our clients and partners around the world.”

– Dandelyn Koh, Global Brand and PR Lead, VT Markets

Celebrating with Exclusive Initiatives

VT Markets first unveiled its 10th anniversary festivities to clients and partners during its Gala Dinner, ” A Billionaire’s Odyssey”, held in Bangkok, Thailand. To commemorate this monumental year, VT Markets will be launching a series of exciting initiatives throughout the year that will engage, inspire, and commemorate.

  • Global Trading Competition: An exciting trading competition inviting traders from around the world to showcase their skills and compete for incredible prizes, reinforcing VT Markets’ commitment to empowering traders at every level.
  • Limited-Edition Merchandise: Exclusive line-up of collectibles to celebrate with our community
  • Branded Content and Promotions: Attractive promotions, and exclusive offers for our community to celebrate the customers who have made this journey possible.
  • Commemorative Video: A tribute to VT Markets’ journey, showcasing key milestones and transformations.

These exciting launches will unfold progressively throughout the year, and details of each will be unveiled on vt10.com and VT Markets’ social media channels.

A Call to the Future

As VT Markets looks ahead, our way forward is of bold ambition, exploration, and innovation. Together, VT Markets will continue to push boundaries, reimagine possibilities, and create new opportunities for everyone it works with. Join us as we step boldly “Into Tomorrow.”

About VT Markets

VT Markets is a regulated multi-asset broker with a presence in over 160 countries as of today. It has earned numerous international accolades including Best Online Trading and Fastest Growing Broker. In line with its mission to make trading accessible to all, VT Markets offers comprehensive access to over 1,000 financial instruments and clients benefit from a seamless trading experience via its award-winning mobile application.

For more information, please visit the official VT Markets website or email us at info@vtmarkets.com. Alternatively, follow VT Markets on Facebook, Instagram, or LinkedIn.

“Homecoming”, First Documentary of Ecological Survey of Tiexian Jiao and Niu’e Jiao Released

BEIJING, April 28, 2025 /PRNewswire/ — On April 25, CMG Voice of the South China Sea released the documentary Homecoming, revealing the truth about the coral reef ecosystems in the Nansha Qundao through on-site scientific investigation.

Recent professional marine ecological surveys by Chinese scientists, comparing remote sensing data from 2016 to 2024, found that the overall coverage of reef-building corals in the Tiexian Jiao had decreased by 68.9%. The investigation further identified that human activities on the nearby Zhongye Dao triggered crown-of-thorns starfish outbreaks, which became the primary factor in the rapid decline of coral coverage.

Meanwhile, Chinese scientists discovered large colonies of the greater crested tern—a priority species for national protection—nesting on cays at Tiexian Jiao and Niu’e Jiao. These cays are formed naturally and are unrelated to coral dumping.

The bilingual documentary Homecoming features interviews with scientists involved in the survey, with Southeast Asian marine ecology experts and international strategists. Through authentic footage and rigorous data comparisons, it delivers a clear message to the global community: environmental degradation is an urgent challenge for all nations, and ocean governance and cooperation is the shared responsibility of all countries.

Homecoming employs high-definition footage, hand-drawn illustrations, and 3D animation to reveal how the biological rhythms of greater crested terns—their breeding and migration—have always been intertwined with the environment. Through the annual story of “migratory birds” in the South China Sea, this newly released documentary appeals to regional nations adopting a more responsible approach in preserving the fragile coral reef ecosystem of the South China Sea—a homeland for both the seabirds and humanity.

Homecoming First Documentary of Ecological Survey of Tiexian Jiao and Niu’e Jiao Released
Homecoming First Documentary of Ecological Survey of Tiexian Jiao and Niu’e Jiao Released